How much does a box of genuine lorlatinib cost? The minimum price for generic drugs is about one to two thousand
Lorlatinib is an oral tyrosine kinase inhibitor designed to treat patients with non-small cell lung cancer (NSCLC), particularly those with ALK (tyrosine kinase) and ROS1 (ROS Patients with proto-oncogene 1) gene mutations. ALK and ROS1mutations are drivers of tumor growth and spread in some NSCLC patients.
Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. Please consult the local hospital pharmacy for details. There are original lorlatinib drugs and cheaper generic drugs abroad. The cheaper ones are the original drug from Turkey, which costs more than 1,000 yuan, and the original drug from Hong Kong, China, which costs about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.

Lorlatinib is a third-generation tyrosine kinase inhibitor that is characterized by a broader inhibition of mutated ALK and ROS1 than earlier drugs. This drug blocks the growth and division of tumor cells by interfering with the abnormal signaling pathways of these genes, thereby inhibiting the development of cancer.
Due to its broad spectrum and potency, lorlatinib has demonstrated significant efficacy in the treatment of ALK or ROS1 positive NSCLC patients. In addition, lorlatinib has also been proven to have certain efficacy in some patients who are resistant to traditional ALK inhibitors, making it an important option in the treatment of lung cancer.
Although lorlatinib has shown good efficacy in the treatment of lung cancer, patients and physicians still need to closely monitor patient responses and possible side effects. Because each patient's condition is unique, treatment options may need to be tailored based on individual characteristics to maximize efficacy and reduce potential adverse effects.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)